Co-localization of GSTP1 and JNK in transitional cell carcinoma of urinary bladder

Marija Pljesa-Ercegovac1, Ana Savic-Radojevic, Tamara Kravic-Stevovic

  • 1Faculty of Medicine, Institute of Medical and Clinical Biochemistry, University of Belgrade, Belgrade Serbia.

Insights

Glutathione S-transferase P1 (GSTP1) overexpression in bladder cancer (TCC) inhibits apoptosis by interacting with c-Jun NH2-terminal kinase (JNK). This study confirms a direct GSTP1-JNK complex in TCC, revealing a novel therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Transitional cell carcinoma (TCC) of the urinary bladder frequently overexpresses glutathione S-transferase P1 (GSTP1).
  • Upregulated GSTP1 is associated with inhibited apoptosis in TCC.
  • GSTP1's antiapoptotic role may involve interaction with c-Jun NH2-terminal kinase (JNK).

Purpose of the Study:

  • To investigate the direct protein-protein interaction between GSTP1 and JNK in TCC.
  • To determine if GSTP1-JNK complexes are present in human TCC specimens.
  • To elucidate the mechanism of GSTP1-mediated apoptosis inhibition in TCC.

Main Methods:

  • Immunoprecipitation and Western blotting were used to detect GSTP1/JNK complexes in 20 TCC surgical specimens.
  • Immunofluorescence confocal microscopy was employed to assess the co-localization of GSTP1 and JNK in the 5637 TCC cell line.

Main Results:

  • The study provides the first evidence of GSTP1/JNK complexes in all analyzed TCC samples.
  • Co-localization of GSTP1 and JNK was confirmed in the 5637 TCC cell line.
  • These findings indicate a direct interaction between GSTP1 and JNK within TCC cells.

Conclusions:

  • GSTP1 directly interacts with JNK in TCC.
  • This interaction likely underlies GSTP1's role in inhibiting apoptosis in TCC.
  • Targeting the GSTP1-JNK interaction may offer a novel therapeutic strategy for TCC.

Related Concept Videos